https://www.fortunebusinessinsights.com/medical-marijuana-market-102609
https://www.fortunebusinessinsights.com/medical-marijuana-market-102609
The global medical marijuana market was valued at USD 6,338.1 million in 2018 and is anticipated to
reach USD 26,920.4 million by 2026, exhibiting an impressive CAGR of 20.4% during the forecast period.
In 2018, North America dominated the global landscape, holding a substantial market share of 94.59%.
The medical marijuana market represents a rapidly evolving segment of the global healthcare industry,
driven by growing recognition of cannabis’s therapeutic potential. As more countries move toward
legalization and regulation, medical marijuana is being increasingly adopted for the treatment of a wide
range of conditions, including chronic pain, neurological disorders, cancer-related symptoms, and
mental health issues. Advances in cultivation, formulation, and delivery methods are improving product
quality and expanding options for patients. At the same time, shifting public attitudes, increased
investment in research, and supportive government policies are helping to reduce stigma and encourage
broader acceptance. As the regulatory landscape continues to mature, the Medical Marijuana Market is
expected to see sustained growth and innovation, paving the way for more personalized and effective
treatment alternatives in modern medicine.
Continue reading for more details:
https://www.fortunebusinessinsights.com/medical-marijuana-market-102609
Market Segmentation:
The Medical Marijuana Market can be segmented based on product type, application, and distribution
channel:
By Product Type:
Raw Flower: Traditional form used for smoking or vaporizing.
Oils and Tinctures: Concentrated extracts administered sublingually or added to food and
beverages.
Capsules and Edibles: Oral consumption methods offering controlled dosages.
Topicals: Creams and lotions applied to the skin for localized relief.
By Application:
Chronic Pain Management: Utilized for conditions like arthritis and back pain.
Neurological Disorders: Applied in treating epilepsy, multiple sclerosis, and Parkinson's
disease.
Mental Health: Used for anxiety, depression, and PTSD.
Cancer Treatment: Assists in alleviating chemotherapy-induced nausea and stimulating
appetite.
By Distribution Channel:
Hospital Pharmacies: Dispensing under medical supervision.
Retail Pharmacies: Accessible to patients with prescriptions.
Online Platforms: Offering convenience and broader reach.
List of key companies profiled in Medical Marijuana Market:
Canopy Growth Corporation
Aurora Cannabis
Aphria Inc.
CannTrust Holdings
GW Pharmaceuticalss
MedReleaf Corp
ABcann Medicinals, Inc.
Emerald Health Therapeutics
Green Relief Inc.
The Cronos Group
Medical Marijuana, Inc.
Others
Market Growth:
The Medical Marijuana Market is on an upward trajectory, fueled by the rising prevalence of chronic
diseases, advancements in cannabis research, and the development of novel delivery methods. The
growing recognition of cannabis's potential in managing conditions such as chronic pain, neurological
disorders, and mental health issues contributes to the market's expansion. Additionally, the integration
of medical marijuana into treatment protocols and the increasing number of healthcare professionals
endorsing its use further bolster market growth.
Restraining Factors:
Despite the rising demand and potential therapeutic benefits, the Medical Marijuana Market faces
several restraining factors that could impede its growth. One of the most significant challenges is the
inconsistent and often restrictive regulatory landscape across different regions. Many countries and
jurisdictions have yet to legalize medical marijuana or have imposed strict limitations that restrict
patient access and hinder market development. Additionally, the lingering social stigma surrounding
cannabis use continues to affect public perception and discourage patients from seeking cannabis-based
treatments. The lack of sufficient clinical evidence and standardized dosing protocols presents another
obstacle, as healthcare providers are often hesitant to prescribe medical marijuana without well-defined
guidelines. Furthermore, supply chain inconsistencies, including quality control issues and the limited
scalability of cultivation operations, can lead to product shortages or variability in treatment efficacy,
further weakening consumer trust in medical cannabis products.
Regional Analysis:
The Medical Marijuana Market displays varied growth patterns across global regions, influenced by legal
frameworks, healthcare infrastructure, and societal attitudes. North America remains the dominant
region in the market, primarily due to the early adoption of medical cannabis in the United States and
Canada. These countries offer a well-established regulatory environment, advanced research initiatives,
and widespread patient acceptance. Europe is rapidly emerging as a key growth area, with nations such
as Germany, the United Kingdom, and the Netherlands actively expanding their medical cannabis
programs and supporting clinical research. The Asia-Pacific region is witnessing gradual market entry,
particularly in countries like Australia, New Zealand, and Thailand, where evolving regulations and
growing awareness are creating a supportive environment for medical marijuana. In Latin America,
countries such as Colombia, Brazil, and Mexico are establishing themselves as both producers and
consumers, benefiting from favorable climate conditions and progressive legislation. Meanwhile, the
Middle East and Africa are in the early stages of market development, with Israel leading in cannabis
sales@fortunebusinessinsights.com
research and innovation, while other nations cautiously explore regulatory reforms and potential
integration into healthcare systems.
Key Industry Developments:
In July 2021, Jushi Holdings Inc. revealed its acquisition of OhiGrow LLC, a licensed cultivator of
medical cannabis in Ohio. This acquisition allows Jushi to secure biomass for the production of
medical marijuana products.
In June 2021, Canopy Growth Corporation completed its acquisition of Supreme Cannabis
Company, Inc. With the inclusion of Supreme's 7ACRES and 7ACRES Craft Collective, Canopy
strengthened its market position and expanded its production capacity.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road,
Baner, Pune-411045,
Maharashtra, India.
Phone: U.S.: +1 424 253 0390
U.K.: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com